Ειδήσεις: INSMED | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 18:06 yahoo.com

Stifel Lifts PT on Insmed Incorporated (INSM) to $208 From $205 – Here’s Why

Insmed Stifel price target earnings outlook pipeline stock upgrade

30/03 16:55 investing.com

Insmed stock gains on UTHR trial read-through, Morgan Stanley upgrade

Insmed UTHR trial Morgan Stanley stock upgrade urea cycle disorders biotech

30/03 08:10 defenseworld.net

Equities Analysts Issue Forecasts for Insmed Q2 Earnings

Insmed HC Wainwright Q2 2026 EPS biopharmaceutical analyst forecast Buy rating

25/03 10:12 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Raised to $213.00 at Bank of America

Insmed price target Bank of America Royal Bank of Canada Citigroup HC Wainwright

25/03 09:36 defenseworld.net

Leerink Partners Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock Price

Insmed Leerink Partners price target outperform rating mixed analyst views biopharmaceutical

24/03 20:42 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Cut to $175.00 by Analysts at Wells Fargo & Company

Insmed price target Wells Fargo Royal Bank of Canada Rothschild Weiss Ratings

23/03 16:59 investing.com

Insmed shares rise as Arikayce trial data point to larger market opportunity

Insmed Arikayce clinical trial market opportunity biotech shares

23/03 13:00 statnews.com

STAT+: Insmed drug benefits patients with rare, bacterial lung disease, study shows

Insmed Arikayce MAC mycobacterium avium complex lung infection accelerated approval

17/03 16:32 yahoo.com

Artisan Small Cap Fund Sold Insmed (INSM) on Valuation Consideration

Artisan Small Cap Fund Insmed valuation concerns biotech divestment portfolio adjustment

17/03 16:32 yahoo.com

Artisan Small Cap Fund Sold Insmed (INSM) on Valuation Consideration

Artisan Small Cap Fund Insmed valuation concerns biotech divestment portfolio adjustment

Loading...